iRhythm Holdings, Inc. (IRTC) stock
IRTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/303% above fair value
$94.87+5.20 (+5.80%)
Close on Nov 18, 2026Market cap $3.13BP/E –Yield –
iRhythm revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
iRhythm's revenue for the twelve months ending Jun 30, 2026 was $825.34M, up 25.6% year over year. For fiscal 2025 it was $747.14M, up 26.2% from the year before. Over ten years it grew 35.4% a year on average. The highest annual figure on record is $747.14M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $747.14M | +26.2% |
| FY2024 | Dec 31, 2024 | $591.84M | +20.1% |
| FY2023 | Dec 31, 2023 | $492.68M | +19.9% |
| FY2022 | Dec 31, 2022 | $410.92M | +27.3% |
| FY2021 | Dec 31, 2021 | $322.83M | +21.7% |
| FY2020 | Dec 31, 2020 | $265.17M | +23.6% |
| FY2019 | Dec 31, 2019 | $214.55M | +45.7% |
| FY2018 | Dec 31, 2018 | $147.28M | +48.6% |
| FY2017 | Dec 31, 2017 | $99.13M | +54.7% |
| FY2016 | Dec 31, 2016 | $64.07M | +77.3% |
| FY2015 | Dec 31, 2015 | $36.14M | +66.2% |
| FY2014 | Dec 31, 2014 | $21.75M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $224.17M | +20.1% |
| Q1 FY2026 | Mar 31, 2026 | $199.39M | +25.7% |
| Q4 FY2025 | Dec 31, 2025 | $208.89M | +27.1% |
| Q3 FY2025 | Sep 30, 2025 | $192.88M | +30.7% |
| Q2 FY2025 | Jun 30, 2025 | $186.69M | +26.1% |
| Q1 FY2025 | Mar 31, 2025 | $158.68M | +20.3% |
| Q4 FY2024 | Dec 31, 2024 | $164.33M | +24.0% |
| Q3 FY2024 | Sep 30, 2024 | $147.54M | +18.4% |
| Q2 FY2024 | Jun 30, 2024 | $148.05M | +19.3% |
| Q1 FY2024 | Mar 31, 2024 | $131.93M | +18.4% |
| Q4 FY2023 | Dec 31, 2023 | $132.51M | +17.7% |
| Q3 FY2023 | Sep 30, 2023 | $124.60M | +20.0% |
| Q2 FY2023 | Jun 30, 2023 | $124.13M | +21.6% |
| Q1 FY2023 | Mar 31, 2023 | $111.44M | +20.6% |
| Q4 FY2022 | Dec 31, 2022 | $112.62M | +37.7% |
| Q3 FY2022 | Sep 30, 2022 | $103.88M | +21.6% |
| Q2 FY2022 | Jun 30, 2022 | $102.05M | +25.6% |
| Q1 FY2022 | Mar 31, 2022 | $92.38M | +24.3% |
| Q4 FY2021 | Dec 31, 2021 | $81.80M | +3.8% |
| Q3 FY2021 | Sep 30, 2021 | $85.43M | +18.7% |
| Q2 FY2021 | Jun 30, 2021 | $81.28M | +59.8% |
| Q1 FY2021 | Mar 31, 2021 | $74.31M | +17.0% |
| Q4 FY2020 | Dec 31, 2020 | $78.81M | +33.3% |
| Q3 FY2020 | Sep 30, 2020 | $71.94M | +31.6% |
| Q2 FY2020 | Jun 30, 2020 | $50.88M | -3.0% |
| Q1 FY2020 | Mar 31, 2020 | $63.54M | +31.4% |
| Q4 FY2019 | Dec 31, 2019 | $59.10M | +41.5% |
| Q3 FY2019 | Sep 30, 2019 | $54.67M | +42.2% |
| Q2 FY2019 | Jun 30, 2019 | $52.44M | +48.6% |
| Q1 FY2019 | Mar 31, 2019 | $48.33M | +52.2% |
| Q4 FY2018 | Dec 31, 2018 | $41.78M | +48.3% |
| Q3 FY2018 | Sep 30, 2018 | $38.44M | +53.5% |
| Q2 FY2018 | Jun 30, 2018 | $35.29M | +48.0% |
| Q1 FY2018 | Mar 31, 2018 | $31.76M | +48.2% |
| Q4 FY2017 | Dec 31, 2017 | $28.18M | +50.7% |
| Q3 FY2017 | Sep 30, 2017 | $25.04M | +49.2% |
| Q2 FY2017 | Jun 30, 2017 | $23.85M | – |
| Q1 FY2017 | Mar 31, 2017 | $21.44M | – |
| Q4 FY2016 | Dec 31, 2016 | $18.70M | – |
| Q3 FY2016 | Sep 30, 2016 | $16.78M | – |
See a number that looks wrong?